Evidence map›Paper›PMID 34234167›Full record

ArticleScientific reports2021

Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.

Rong Liu, Pei Wu, Pauline Ogrodzki, Sally Mahmoud, Ke Liang, Pengjuan Liu, Stephen S Francis, Hanif Khalak, Denghui Liu, Junhua Li and 27 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors at 6 institutions in 3 countries.

Rong LiuGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Pei WuGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Pauline OgrodzkiGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Sally MahmoudGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Ke LiangMGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Pengjuan LiuMGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Stephen S FrancisDepartment of Neurological Surgery, University of California, San Francisco, USA.
Hanif KhalakGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Denghui LiuLaboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China.
Junhua LiBGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Tao MaMGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Fang ChenMGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Weibin LiuBGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Xinyu HuangMGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Wenjun HeLaboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China.
Zhaorong YuanLaboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China.
Nan QiaoLaboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China.
Xin MengLaboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China.
Budoor AlqarniGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Javier QuilezGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Vinay KusumaGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Long LinBGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Xin JinBGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Chongguang YangDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, USA.
Xavier AntonGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Ashish KoshyGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Huanming YangBGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Xun XuBGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Jian WangBGI-Shenzhen, Shenzhen, 518083, Guangdong, China.
Peng XiaoGroup42 Healthcare, Abu Dhabi, United Arab Emirates.
Nawal Al KaabiSEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Mohammed Saifuddin FasihuddinSEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Francis Amirtharaj SelvarajSEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Stefan WeberSEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Farida Ismail Al HosaniDepartment of Health, Abu Dhabi, United Arab Emirates.
Siyang LiuBGI-Shenzhen, Shenzhen, 518083, Guangdong, China. liusiyang@bgi.com.
Walid Abbas ZaherGroup42 Healthcare, Abu Dhabi, United Arab Emirates. Walid.Zaher@g42.ai.
BGI Group (China) · CNHuawei Technologies (China) · CNAbu Dhabi Health Services · AESun Yat-sen University · CNUniversity of California, San Francisco · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cross-settlement human-to-human transmission was related to the local business activity. Perhaps surprisingly, at least 5% of the population were co-infected by SARS-CoV-2 of multiple clades within the same host. We also discovered an enrichment of cytosine-to-uracil mutation among the viral population collected from the nasopharynx, that is different from the adenosine-to-inosine change previously reported in the bronchoalveolar lavage fluid samples and a previously unidentified upregulation of APOBEC4 expression in nasopharynx among infected patients, indicating the innate immune host response mediated by ADAR and APOBEC gene families could be tissue-specific. The genomic epidemiological and molecular biological knowledge reported here provides new insights for the SARS-CoV-2 evolution and transmission and points out future direction on host-pathogen interaction investigation.

Indexed as

GenomicsImmunity, InnateMutationAdultCoinfectionCOVID-19Cytidine DeaminaseFemaleGene Expression ProfilingGenome, ViralHumansMaleMiddle AgedNasopharynxOrgan SpecificitySARS-CoV-2APOBEC4 protein, humanCytidine Deaminase

Identifiers

PMID34234167
PMCPMC8263779
OpenAlexW3197563078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.